A. Stek

发表

Safety and Pharmacokinetics of Hyperimmune Anti-Human Immunodeficiency Virus (HIV) Immunoglobulin Administered to HIV-Infected Pregnant Women and Their Newborns

J. Lambert, L. Mofenson, C. Fletcher, 1997 .

Reduced indinavir exposure during pregnancy.

D. H. Watts, E. Capparelli, T. Cressey, 2013, British journal of clinical pharmacology.

Correlates of perinatal depression in HIV-infected women.

W. Mack, E. Operskalski, R. Karim, 2009, AIDS patient care and STDs.

Profile of Chronic Comorbid Conditions and Obstetrical Complications among Pregnant Women with HIV and Receiving Antiretroviral Therapy in the United States.

E. Livingston, J. Read, D. Shapiro, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Lopinavir and tenofovir interaction observed in non‐pregnant adults altered during pregnancy

E. Capparelli, J. Momper, M. Mirochnick, 2021, Journal of clinical pharmacy and therapeutics.

Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy

E. Capparelli, E. Joao, S. Burchett, 2020, Antimicrobial Agents and Chemotherapy.

Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV

K. Anastos, M. Young, H. Minkoff, 2004, AIDS.

Antiretroviral medications during pregnancy for therapy or prophylaxis

A. Stek, 2009, Current HIV/AIDS reports.

Analysis of Standard Methods for Diagnosing Vaginitis: HIV Infection Does Not Complicate the Diagnosis of Vaginitis

D. Passaro, R. Hershow, E. Golub, 2007, Journal of lower genital tract disease.

Evaluation of a rapid optical immunoassay-based test for group B streptococcus colonization in intrapartum patients

R. Samadi, A. Stek, J. Greenspoon, 2001, The Journal of maternal-fetal medicine.

Factors Associated With Lack of Viral Suppression at Delivery Among Highly Active Antiretroviral TherapyNaive Women With HIV

M. Hughes, I. Katz, E. Leister, 2015, Annals of Internal Medicine.

Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy.

E. Livingston, A. Bardeguez, K. Patel, 2010, The Journal of infectious diseases.

Safety and Pharmacokinetics of Nelfinavir Coadministered With Zidovudine and Lamivudine in Infants During the First 6 Weeks of Life

M. Hughes, L. Mofenson, J. Connor, 2005, Journal of acquired immune deficiency syndromes.

Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine

D. Harris, J. Lambert, L. Mofenson, 2000, AIDS.

Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies

M. Schluchter, J. Goedert, P. Boisse, 2001, AIDS.

Adherence to Antiretrovirals Among US Women During and After Pregnancy

J. Lindsey, S. Cohn, A. Bardeguez, 2008, Journal of acquired immune deficiency syndromes.

Etravirine Pharmacokinetics in HIV-Infected Pregnant Women

C. Fletcher, M. V. van Kasteren, E. Capparelli, 2016, Front. Pharmacol..

Darunavir pharmacokinetics with an increased dose during pregnancy.

E. Capparelli, M. Mirochnick, N. Chakhtoura, 2020, Journal of acquired immune deficiency syndromes.

Low Bioactive Vitamin D Is Associated with Pregnancy-Induced Hypertension in a Cohort of Pregnant HIV-Infected Women Sampled Over a 23-Year Period

E. Operskalski, R. Pandian, A. Kovacs, 2019, American Journal of Perinatology.

Evaluation of a rapid optical immunoassay-based test for group B streptococcus colonization in intrapartum patients.

R. Samadi, A. Stek, J. Greenspoon, 2001 .

Maternal Toxicity With Continuous Nevirapine in Pregnancy: Results From PACTG 1022

Lee-Jen Wei, D. H. Watts, J. Hitti, 2004, Journal of acquired immune deficiency syndromes.

Immunomodulatory factors in cervicovaginal secretions from pregnant and non-pregnant women: A cross-sectional study

G. Aldrovandi, J. Walter, W. Decker, 2011, BMC infectious diseases.

Pharmacokinetics and Safety of Nelfinavir When Used in Combination with Zidovudine and Lamivudine in HIV-Infected Pregnant Women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353

M. Hughes, L. Mofenson, J. Connor, 2008, HIV clinical trials.

Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV

E. Barr, E. Acosta, E. Capparelli, 2018, AIDS.

Effects of Initiating Raltegravir-Based Versus Efavirenz-Based Antiretroviral Regimens During Pregnancy on Weight Changes and Perinatal Outcomes: NICHD P1081

E. Joao, G. Duarte, A. Violari, 2022, Journal of acquired immune deficiency syndromes.

Predictors of Viremia in Postpartum Women on Antiretroviral Therapy

J. Currier, K. R. Amico, E. Joao, 2019, Journal of acquired immune deficiency syndromes.

Efavirenz Pharmacokinetics during Pregnancy and Infant Washout

T. Cressey, M. Mirochnick, B. Best, 2019, Antiviral therapy.

Risk factors for trichomoniasis among women with human immunodeficiency virus (HIV) infection at a public clinic in Los Angeles County, California: implications for HIV prevention.

P. Kerndt, A. Kovacs, L. Muderspach, 1998, The American journal of tropical medicine and hygiene.

Mode of delivery and the risk of vertical transmission of HIV-1.

A. Stek, K. Beckerman, A. Morris, 1999, The New England journal of medicine.

Atazanavir Pharmacokinetics With and Without Tenofovir During Pregnancy

Chengcheng Hu, E. Capparelli, S. Burchett, 2011, Journal of acquired immune deficiency syndromes.

Population Pharmacokinetics of Tenofovir in Pregnant and Postpartum Women Using Tenofovir Disoproxil Fumarate

E. Capparelli, J. Momper, T. Cressey, 2020, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV: Results from IMPAACT P1026s.

R. Haubrich, E. Barr, E. Capparelli, 2020, AIDS.

Impact of pregnancy on abacavir pharmacokinetics

S. Spector, Chengcheng Hu, J. Connor, 2006, AIDS.

Pharmacokinetics of Saquinavir plus Low-Dose Ritonavir in Human Immunodeficiency Virus-Infected Pregnant Women

M. Hughes, L. Mofenson, E. Acosta, 2004, Antimicrobial Agents and Chemotherapy.

Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero.

R. Tarone, H. Kessler, C. Chougnet, 1999, AIDS.

Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.

J. Lambert, L. Mofenson, P. Reichelderfer, 1999, The Journal of infectious diseases.

Depo‐medroxyprogesterone in Women on Antiretroviral Therapy: Effective Contraception and Lack of Clinically Significant Interactions

J. Park, S. Cohn, Song Yu, 2007, Clinical pharmacology and therapeutics.

Interactions Between Etonogestrel-Releasing Contraceptive Implant and Three Antiretroviral Regimens.

E. Capparelli, M. Mirochnick, N. Chakhtoura, 2021, Contraception.

HCV viremia is associated with drug use in young HIV-1 and HCV coinfected pregnant and non-pregnant women.

A. Kovacs, F. Kramer, J. Homans, 2005, Addiction.

Rilpivirine Plasma and Cervicovaginal Concentrations in Women During Pregnancy and Postpartum

E. Capparelli, A. Kashuba, M. Mirochnick, 2018, Journal of acquired immune deficiency syndromes.

Reduced lopinavir exposure during pregnancy

Chengcheng Hu, E. Capparelli, S. Burchett, 2006, AIDS.

Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women

E. Capparelli, S. Burchett, T. Cressey, 2016, Journal of acquired immune deficiency syndromes.

Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s

E. Barr, E. Capparelli, M. Paul, 2022, Journal of acquired immune deficiency syndromes.

Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women.

D. Hawkins, M. V. van Kasteren, K. Kabeya, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women

L. Mofenson, E. Capparelli, S. Burchett, 2015, Journal of acquired immune deficiency syndromes.

Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV

E. Barr, E. Acosta, M. Purswani, 2018, AIDS.

Raltegravir Pharmacokinetics During Pregnancy

F. Aweeka, D. H. Watts, E. Capparelli, 2014, Journal of acquired immune deficiency syndromes.

Efavirenz Pharmacokinetics During the Third Trimester of Pregnancy and Postpartum

E. Capparelli, T. Cressey, Y. Huo, 2012, Journal of acquired immune deficiency syndromes.

The relationship of pregnancy to the use of highly active antiretroviral therapy.

R. Greenblatt, L. Ahdieh, H. Minkoff, 2001, American journal of obstetrics and gynecology.

Lopinavir Tablet Pharmacokinetics With an Increased Dose During Pregnancy

Chengcheng Hu, E. Capparelli, S. Burchett, 2010, Journal of acquired immune deficiency syndromes.

Antiretroviral treatment in pregnancy

A. Stek, 2008, Current opinion in HIV and AIDS.

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

M. Hughes, L. Mofenson, D. Wara, 2002, The New England journal of medicine.

Maternal and fetal cardiovascular responses to methamphetamine in the pregnant sheep.

R. Baker, U. Lang, K. Clark, 1993, American journal of obstetrics and gynecology.

Fetal responses to maternal and fetal methamphetamine administration in sheep.

R. Baker, U. Lang, K. Clark, 1995, American journal of obstetrics and gynecology.

Missed Opportunities for Prevention of Mother-to-Child Transmission of Human Immunodeficiency Virus.

J. Read, G. Scott, D. Muenz, 2017, Obstetrics and gynecology.

“We Are Not Different than Others”: A Qualitative Study of the Lived Experience of Hispanic Adolescents and Young Adults Living with Perinatally Acquired HIV

Cynthia D. Fair, E. Operskalski, J. Homans, 2023, International journal of environmental research and public health.

Birth Weight and Preterm Delivery Outcomes of Perinatally vs Nonperinatally Human Immunodeficiency Virus-Infected Pregnant Women in the United States: Results From the PHACS SMARTT Study and IMPAACT P1025 Protocol

M. McNichols, S. Bewley, W. Borkowsky, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Postpartum Viral Load Rebound in HIV-1–Infected Women Treated with Highly Active Antiretroviral Therapy: AIDS Clinical Trials Group Protocol A5150

S. Kalams, F. Aweeka, S. Cohn, 2011, HIV clinical trials.

PHARMACOKINETIC EXPOSURE AND VIROLOGIC RESPONSE IN HIV-1 INFECTED PREGNANT WOMEN TREATED WITH LOPINAVIR/RITONAVIR: AIDS CLINICAL TRIALS GROUP PROTOCOL A5153S: A SUBSTUDY TO A5150.

F. Aweeka, S. Cohn, Xin Sun, 2015, Jacobs journal of AIDS/HIV.

Lopinavir Exposure With an Increased Dose During Pregnancy

Chengcheng Hu, E. Capparelli, S. Burchett, 2008, Journal of acquired immune deficiency syndromes.

Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy.

S. Urien, E. Capparelli, T. Cressey, 2015, The Journal of antimicrobial chemotherapy.

Pharmacokinetics of an Increased Atazanavir Dose With and Without Tenofovir During the Third Trimester of Pregnancy

D. H. Watts, S. Burchett, T. Cressey, 2013, Journal of acquired immune deficiency syndromes.

Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS Clinical Trials Group A5084.

G. McComsey, J. Aberg, E. Livingston, 2007, American journal of obstetrics and gynecology.

Changing Patterns and Factors Associated With Mode of Delivery Among Pregnant Women With Human Immunodeficiency Virus Infection in the United States.

E. Livingston, J. Read, D. Shapiro, 2018, Obstetrics and gynecology.

Mode of Delivery and Infant Respiratory Morbidity Among Infants Born to HIV-1-Infected Women

E. Livingston, A. Bardeguez, K. Patel, 2010, Obstetrics and gynecology.

Pharmacokinetics of Increased Nelfinavir Plasma Concentrations in Women During Pregnancy and Postpartum

L. Mofenson, E. Capparelli, M. Mirochnick, 2018, Journal of clinical pharmacology.

Complications and Route of Delivery in a Large Cohort Study of HIV-1–Infected Women—IMPAACT P1025

E. Livingston, K. Patel, Y. Huo, 2016, Journal of acquired immune deficiency syndromes.

Adverse Pregnancy Outcomes Among Women Who Conceive on Antiretroviral Therapy

S. Spector, L. Aurpibul, J. Currier, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Low maternal vitamin D is associated with increased risk of congenital and peri/postnatal transmission of Cytomegalovirus in women with HIV

E. Operskalski, R. Pandian, A. Kovacs, 2020, PloS one.

Preliminary studies of cytokine secretion patterns associated with pregnancy in MS patients

K. McCarthy, W. Gilmore, A. Stek, 2004, Journal of the Neurological Sciences.

Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV.

E. Capparelli, M. Paul, S. Burchett, 2021, AIDS.

The effect of protease inhibitors on the cervical mucus of HIV-positive women taking norethindrone contraception

H. Vora, L. Sanchez-Keeland, M. Natavio, 2015, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093.

J. Park, S. Cohn, Song Yu, 2008, Contraception.

HIV in Pregnancy

A. Stek, 2010 .

HIV and Other Sexually Transmitted Infections

A. Stek, 2011 .

The Obstetrical Care and Delivery Experience of Women with Epilepsy in the MONEAD Study

K. Meador, P. Pennell, M. Druzin, 2021, American Journal of Perinatology.

The effect of prenatal highly active antiretroviral therapy on the transmission of congenital and perinatal/early postnatal cytomegalovirus among HIV-infected and HIV-exposed infants.

E. Operskalski, A. Kovacs, F. Kramer, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Zidovudine, Lamivudine, and Nelfinavir Concentrations in Amniotic Fluid and Maternal Serum

E. Acosta, Y. Bryson, M. Mirochnick, 2009 .

Pharmacokinetics of Atazanavir Boosted With Cobicistat in Pregnant and Postpartum Women With HIV

E. Capparelli, M. Paul, J. Momper, 2021, Journal of acquired immune deficiency syndromes.

Assessing the efficacy of magnesium oxide and riboflavin as preventative treatment of migraines in pregnancy.

L. Kalayjian, A. Stek, M. Wilson, 2022, Archives of gynecology and obstetrics.

Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women

E. Capparelli, S. Burchett, T. Cressey, 2016, Journal of acquired immune deficiency syndromes.

Incorporation of Zidovudine into Cord Blood DNA of Infants and Peripheral Blood DNA of Their HIV‐1‐Positive Mothers

C. Chougnet, G. Shearer, M. Poirier, 2000, Annals of the New York Academy of Sciences.

Mode of delivery and the risk of vertical transmission of HIV-1.

A. Stek, K. Beckerman, A. Morris, 1999, The New England journal of medicine.